SNY logo

Sanofi (SNY) Operating profit

annual operating profit:

$10.24B-$1.01B(-8.97%)
December 1, 2024

Summary

  • As of today (April 13, 2025), SNY annual operating income is $10.24 billion, with the most recent change of -$1.01 billion (-8.97%) on December 1, 2024.
  • During the last 3 years, SNY annual operating profit has fallen by -$581.36 million (-5.37%).
  • SNY annual operating profit is now -18.26% below its all-time high of $12.53 billion, reached on December 31, 2022.

Performance

SNY Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSNYincome statement metrics

quarterly operating profit:

$1.71B-$2.79B(-62.00%)
December 1, 2024

Summary

  • As of today (April 13, 2025), SNY quarterly operating income is $1.71 billion, with the most recent change of -$2.79 billion (-62.00%) on December 1, 2024.
  • Over the past year, SNY quarterly operating profit has stayed the same.
  • SNY quarterly operating profit is now -83.93% below its all-time high of $10.64 billion, reached on March 31, 2008.

Performance

SNY quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSNYincome statement metrics

TTM operating profit:

$11.09B-$395.56M(-3.45%)
December 1, 2024

Summary

  • As of today (April 13, 2025), SNY TTM operating income is $11.09 billion, with the most recent change of -$395.56 million (-3.45%) on December 1, 2024.
  • Over the past year, SNY TTM operating profit has stayed the same.
  • SNY TTM operating profit is now -29.85% below its all-time high of $15.80 billion, reached on December 31, 2008.

Performance

SNY TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSNYincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

SNY Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-9.0%0.0%0.0%
3 y3 years-5.4%-41.2%+0.6%
5 y5 years+27.4%-41.2%+0.6%

SNY Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-18.3%at low-63.5%at low-11.7%+4.1%
5 y5-year-18.3%+27.4%-63.5%at low-11.7%+150.6%
alltimeall time-18.3%+890.4%-83.9%+107.9%-29.9%+286.8%

Sanofi Operating profit History

DateAnnualQuarterlyTTM
Dec 2024
$10.24B(-9.0%)
$1.71B(-62.0%)
$11.09B(-3.4%)
Sep 2024
-
$4.50B(+83.1%)
$11.48B(+6.8%)
Jun 2024
-
$2.46B(+1.4%)
$10.75B(+0.9%)
Mar 2024
-
$2.42B(+15.2%)
$10.65B(-5.4%)
Dec 2023
$11.25B(-10.2%)
$2.10B(-44.1%)
$11.25B(-2.7%)
Sep 2023
-
$3.76B(+59.6%)
$11.57B(-7.4%)
Jun 2023
-
$2.36B(-22.2%)
$12.49B(-0.5%)
Mar 2023
-
$3.03B(+25.2%)
$12.56B(+1.0%)
Dec 2022
$12.53B(+15.8%)
$2.42B(-48.3%)
$12.43B(+2.8%)
Sep 2022
-
$4.68B(+93.1%)
$12.10B(+8.1%)
Jun 2022
-
$2.42B(-16.6%)
$11.19B(+1.6%)
Mar 2022
-
$2.91B(+39.6%)
$11.02B(+1.8%)
Dec 2021
$10.82B(+20.1%)
$2.08B(-44.9%)
$10.83B(+23.8%)
Sep 2021
-
$3.78B(+67.8%)
$8.75B(+76.1%)
Jun 2021
-
$2.25B(-17.0%)
$4.97B(+12.3%)
Mar 2021
-
$2.71B(+58.8%)
$4.42B(-47.4%)
Dec 2020
$9.01B(+12.1%)
-
-
Jun 2020
-
$1.71B(-25.0%)
$8.41B(+0.1%)
Mar 2020
-
$2.28B(+36.4%)
$8.41B(+4.7%)
Dec 2019
$8.04B(+8.8%)
$1.67B(-39.3%)
$8.03B(+7.1%)
Sep 2019
-
$2.75B(+61.6%)
$7.50B(+0.6%)
Jun 2019
-
$1.70B(-10.4%)
$7.45B(+0.0%)
Mar 2019
-
$1.90B(+67.1%)
$7.45B(+0.8%)
Dec 2018
$7.39B(-9.4%)
$1.14B(-58.0%)
$7.39B(-3.2%)
Sep 2018
-
$2.71B(+59.0%)
$7.64B(-2.4%)
Jun 2018
-
$1.70B(-7.5%)
$7.83B(-2.1%)
Mar 2018
-
$1.84B(+33.1%)
$8.00B(-1.7%)
Dec 2017
$8.16B(-2.1%)
$1.38B(-52.3%)
$8.14B(-5.1%)
Sep 2017
-
$2.90B(+54.8%)
$8.57B(+1.3%)
Jun 2017
-
$1.87B(-5.2%)
$8.46B(+0.1%)
Mar 2017
-
$1.98B(+8.6%)
$8.46B(+1.4%)
Dec 2016
$8.33B(+5.2%)
$1.82B(-34.8%)
$8.34B(+5.5%)
Sep 2016
-
$2.79B(+49.5%)
$7.90B(+5.7%)
Jun 2016
-
$1.87B(+0.6%)
$7.48B(-3.0%)
Mar 2016
-
$1.86B(+34.1%)
$7.71B(-0.5%)
Dec 2015
$7.92B(-11.7%)
$1.38B(-41.6%)
$7.74B(-8.7%)
Sep 2015
-
$2.37B(+13.1%)
$8.48B(-3.6%)
Jun 2015
-
$2.10B(+10.6%)
$8.80B(+0.0%)
Mar 2015
-
$1.89B(-10.7%)
$8.79B(-1.6%)
Dec 2014
$8.96B(+6.1%)
$2.12B(-21.1%)
$8.94B(-2.2%)
Sep 2014
-
$2.69B(+28.4%)
$9.14B(+3.5%)
Jun 2014
-
$2.09B(+2.5%)
$8.83B(+4.7%)
Mar 2014
-
$2.04B(-12.1%)
$8.43B(-0.3%)
Dec 2013
$8.44B
$2.32B(-2.3%)
$8.46B(+7.4%)
Sep 2013
-
$2.38B(+40.4%)
$7.88B(-6.0%)
Jun 2013
-
$1.69B(-18.2%)
$8.38B(-8.0%)
DateAnnualQuarterlyTTM
Mar 2013
-
$2.07B(+18.7%)
$9.11B(-10.0%)
Dec 2012
$10.13B(-4.8%)
$1.74B(-39.4%)
$10.12B(-11.1%)
Sep 2012
-
$2.88B(+18.7%)
$11.38B(-4.4%)
Jun 2012
-
$2.42B(-21.4%)
$11.90B(+8.5%)
Mar 2012
-
$3.08B(+2.7%)
$10.97B(+3.8%)
Dec 2011
$10.64B(-5.5%)
$3.00B(-11.7%)
$10.56B(+2.8%)
Sep 2011
-
$3.40B(+128.3%)
$10.27B(+5.9%)
Jun 2011
-
$1.49B(-44.4%)
$9.70B(-14.3%)
Mar 2011
-
$2.68B(-1.3%)
$11.33B(-2.6%)
Dec 2010
$11.25B(+8.4%)
$2.71B(-4.0%)
$11.63B(+10.5%)
Sep 2010
-
$2.82B(-9.3%)
$10.53B(-2.2%)
Jun 2010
-
$3.11B(+4.4%)
$10.76B(+1.5%)
Mar 2010
-
$2.98B(+85.6%)
$10.60B(+2.9%)
Dec 2009
$10.38B(+8.3%)
$1.61B(-47.5%)
$10.30B(+38.7%)
Sep 2009
-
$3.06B(+3.8%)
$7.43B(-10.7%)
Jun 2009
-
$2.95B(+9.9%)
$8.32B(+6.0%)
Mar 2009
-
$2.68B(-311.8%)
$7.85B(-50.3%)
Dec 2008
$9.59B(+14.5%)
-$1.27B(-132.0%)
$15.80B(-440.1%)
Sep 2008
-
$3.95B(+59.3%)
-$4.65B(-570.4%)
Jun 2008
-
$2.48B(-76.7%)
$987.67M(+31.3%)
Mar 2008
-
$10.64B(-149.0%)
$752.20M(-218.2%)
Dec 2007
$8.37B(+11.0%)
-$21.72B(-326.5%)
-$636.49M(-314.3%)
Sep 2007
-
$9.59B(+327.0%)
$296.96M(+249.9%)
Jun 2007
-
$2.25B(-75.7%)
$84.87M(-110.8%)
Mar 2007
-
$9.25B(-144.5%)
-$783.24M(-86.8%)
Dec 2006
$7.54B(+6.0%)
-$20.78B(-321.7%)
-$5.94B(-158.4%)
Sep 2006
-
$9.37B(+580.8%)
$10.16B(+97.2%)
Jun 2006
-
$1.38B(-66.4%)
$5.15B(-7.4%)
Mar 2006
-
$4.09B(-187.5%)
$5.56B(-17.3%)
Dec 2005
$7.12B(+60.0%)
-$4.68B(-207.3%)
$6.73B(+95.2%)
Sep 2005
-
$4.36B(+144.1%)
$3.45B(-38.5%)
Jun 2005
-
$1.79B(-66.0%)
$5.61B(+18.3%)
Mar 2005
-
$5.26B(-166.0%)
$4.74B(+109.6%)
Dec 2004
$4.45B(+28.0%)
-$7.96B(-222.1%)
$2.26B(-64.8%)
Sep 2004
-
$6.52B(+608.2%)
$6.42B(+145.2%)
Jun 2004
-
$921.24M(-66.9%)
$2.62B(+5.3%)
Mar 2004
-
$2.78B(-173.1%)
$2.49B(+38.7%)
Dec 2003
$3.48B(+40.4%)
-$3.81B(-239.9%)
$1.79B(-32.1%)
Sep 2003
-
$2.72B(+244.4%)
$2.64B(+50.0%)
Jun 2003
-
$789.90M(-62.2%)
$1.76B(+14.5%)
Mar 2003
-
$2.09B(-170.6%)
$1.54B(-379.6%)
Dec 2002
$2.48B(+31.2%)
-$2.96B(-260.7%)
-$549.94M(-122.9%)
Sep 2002
-
$1.84B(+224.9%)
$2.41B(+324.9%)
Jun 2002
-
$566.21M
$566.21M
Dec 2001
$1.89B(+29.5%)
-
-
Dec 2000
$1.46B(+40.9%)
-
-
Dec 1999
$1.03B
-
-

FAQ

  • What is Sanofi annual operating income?
  • What is the all time high annual operating profit for Sanofi?
  • What is Sanofi annual operating profit year-on-year change?
  • What is Sanofi quarterly operating income?
  • What is the all time high quarterly operating profit for Sanofi?
  • What is Sanofi quarterly operating profit year-on-year change?
  • What is Sanofi TTM operating income?
  • What is the all time high TTM operating profit for Sanofi?
  • What is Sanofi TTM operating profit year-on-year change?

What is Sanofi annual operating income?

The current annual operating profit of SNY is $10.24B

What is the all time high annual operating profit for Sanofi?

Sanofi all-time high annual operating income is $12.53B

What is Sanofi annual operating profit year-on-year change?

Over the past year, SNY annual operating income has changed by -$1.01B (-8.97%)

What is Sanofi quarterly operating income?

The current quarterly operating profit of SNY is $1.71B

What is the all time high quarterly operating profit for Sanofi?

Sanofi all-time high quarterly operating income is $10.64B

What is Sanofi quarterly operating profit year-on-year change?

Over the past year, SNY quarterly operating income has changed by $0.00 (0.00%)

What is Sanofi TTM operating income?

The current TTM operating profit of SNY is $11.09B

What is the all time high TTM operating profit for Sanofi?

Sanofi all-time high TTM operating income is $15.80B

What is Sanofi TTM operating profit year-on-year change?

Over the past year, SNY TTM operating income has changed by $0.00 (0.00%)
On this page